Omega Reports First Quarter 2025 Results and Recent Developments

In This Article:

Completed $423 Million in New Investments Year-to-Date through April

Increases Full Year Adjusted FFO Guidance

HUNT VALLEY, Md., May 01, 2025--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the "Company" or "Omega") announced today its results for the quarter ended March 31, 2025.

FIRST QUARTER 2025 AND RECENT HIGHLIGHTS

  • Net income for the quarter of $112 million, or $0.33 per common share, compared to $69 million, or $0.27 per common share, for Q1 2024.

  • Nareit Funds From Operations ("Nareit FFO") for the quarter of $184 million, or $0.62 per common share, on 295 million weighted-average common shares outstanding, compared to $153 million, or $0.60 per common share, on 257 million weighted-average common shares outstanding, for Q1 2024.

  • Adjusted Funds From Operations ("Adjusted FFO" or "AFFO") for the quarter of $221 million, or $0.75 per common share, compared to $176 million, or $0.68 per common share, for Q1 2024.

  • Funds Available for Distribution ("FAD") for the quarter of $211 million, or $0.71 per common share, compared to FAD of $168 million, or $0.65 per common share, for Q1 2024.

  • Completed approximately $78 million in Q1 new investments consisting of $58 million in real estate acquisitions and $20 million in real estate loans.

  • Issued 7 million common shares in Q1 for gross proceeds of $264 million.

  • Inspir Embassy Row development in Washington D.C. placed into service in February 2025.

  • Repaid $400 million of senior unsecured notes due January 15, 2025.

  • Completed $344 million in real estate acquisitions in April 2025.

  • Extended the maturity date of the $1.45 billion unsecured revolving credit facility to October 30, 2025.

  • Repaid a $50 million term loan on April 29, 2025.

Nareit FFO, AFFO and FAD are supplemental non-GAAP financial measures the Company believes are useful in evaluating the performance of real estate investment trusts ("REITs"). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.

CEO COMMENTS

Taylor Pickett, Omega’s Chief Executive Officer, stated, "We are pleased with our first quarter results, as we continue to grow FAD per share, while further de-levering the balance sheet. We have accretively invested approximately $423 million year-to-date through April 30th and, as a result, we are increasing our 2025 AFFO guidance to be between $2.95 and $3.01 per share from our previous guidance of between $2.90 and $2.98 per share."

Mr. Pickett continued, "In March, Genesis did not pay its contractual rent of $4.2 million, and we partially pulled a letter of credit to cover the full shortfall. Genesis paid full contractual rent in April and has remained current on all interest obligations on our secured term loan. Genesis’s management has indicated that their current liquidity issues stem from a tightening of their borrowing base by their asset-based lender, as well as professional liability obligations. We believe Omega’s credit position with Genesis remains strong, with our trailing 12-month EBITDAR coverage exceeding 1.6x, as well as significant collateral behind our $118 million term loan."